Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer

Roger Li,Luigi Nocera,Kyle M. Rose,Daniele Raggi,Shreyas Naidu,Chiara Mercinelli,Antonio Cigliola, Valentina Tateo,Damiano Patanè,G. Daniel Grass,Scott M. Gilbert,Wade J. Sexton,Marco Bandini,Marco Moschini,Alberto Briganti,Francesco Montorsi,Philippe E. Spiess,Andrea Necchi

European urology oncology（2024）

引用 0|浏览10

暂无评分

摘要

Improved survival and pathologic response were seen in patients receiving immunotherapy and radical cystectomy for muscle-invasive bladder cancer compared with standard-of-care treatments. Randomized controlled trials are needed to further validate these findings in both the cisplatin-eligible and the cisplatin-ineligible populations.

查看译文

关键词

Muscle-invasive bladder cancer,Pembrolizumab,Neoadjuvant chemotherapy,Radical cystectomy,Outcome analysis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要